STAT3 and hepatocellular carcinoma: Further, we found that reduction of CFHR3 in HCC resulted from miR-590-3p overexpression, promoting phosphorylation of STAT3, suppressing p53 to promote the proliferation and metastasis in HCC cells, which is constricted by STAT3 inhibitor, S3I-201.